AP

Annamaneni Praveen Rao

Active Director Director DIN 08315811
DIN 08315811 First appointment Jan 2019 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Annamaneni Praveen Rao

Data last updated:

Annamaneni Praveen Rao is a Director at Oceaan Bio-Pharma Private Limited (since 2019). The company operates in Business Services.

DIN 08315811
Primary Designation Director
Industry Business Services
First Appointment 02 Jan 2019
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Oceaan Bio-Pharma Private Limited U74999AP2017PTC106064
Director02 Jan 20192017Active

Board colleagues of Annamaneni Praveen Rao

NameDINCompanyDesignation
Sandhilolu Babu08316209Oceaan Bio-Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Oceaan Bio-Pharma Private Limited
Premium access

Shareholding and investment profile for Annamaneni Praveen Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Annamaneni Praveen Rao

Annamaneni Praveen Rao currently holds 1 directorship: Oceaan Bio-Pharma Private Limited (Director, since 02 Jan 2019).

Annamaneni Praveen Rao was first appointed on 02 Jan 2019 as Director at Oceaan Bio-Pharma Private Limited.

The current boards of Annamaneni Praveen Rao's companies include Sandhilolu Babu (Oceaan Bio-Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available